BioClinica Partners with Symbiance

January 26, 2011

Company News Release

BioClinica, Inc. recently announced it has established a strategic partnership with Symbiance Inc., a specialty contract research organization (CRO) based in Princeton Junction, New Jersey. Symbiance concentrates in therapeutic areas relevant to pharmaceutical and biotechnology companies with particular focus in oncology and CNS.

"With their therapeutic expertise and knowledge of the clinical trial space, Symbiance is an excellent partner for BioClinica's offerings. I am confident in the added value this partnership will bring to our mutual clients," said Peter Benton, President of eClinical Solutions for BioClinica.

Symbiance began operations in 1990 to provide clear, precise and timely solutions for the data needs of clinical trial professionals. Symbiance includes a clinical data management unit, biostatistical analysis, and SAS programming divisions supporting Phase I through IV clinical trials.

Related Content:

News